Pfizer seems to have struck gold with its double-dose COVID-19 shot. The drug maker on Wednesday raised its sales forecast for the vaccine this year by nearly a third to $33.5 billion.
The company said it has signed deals for 2.1 billion doses of the vaccine it jointly developed with Germany’s BioNTech, and that could rise further if it signs more contracts. The pair expect to produce 3 billion doses this year. Continue reading “Pfizer raises vaccine sales forecast to $33.5 bln”